Found: 17
Select item for more details and to access through your institution.
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 863, doi. 10.1016/j.clml.2022.07.007
- By:
- Publication type:
- Article
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 853, doi. 10.1016/j.clml.2022.07.001
- By:
- Publication type:
- Article
CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 847, doi. 10.1016/j.clml.2022.07.011
- By:
- Publication type:
- Article
Pediatric Plasma Cell Neoplasms: A Population-Based Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 841, doi. 10.1016/j.clml.2022.07.003
- By:
- Publication type:
- Article
Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 835, doi. 10.1016/j.clml.2022.06.010
- By:
- Publication type:
- Article
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 825, doi. 10.1016/j.clml.2022.06.011
- By:
- Publication type:
- Article
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 812, doi. 10.1016/j.clml.2022.06.012
- By:
- Publication type:
- Article
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 805, doi. 10.1016/j.clml.2022.07.008
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Mechanisms of Resistance to BCL2 Inhibitor Therapy in Chronic Lymphocytic Leukemia and Potential Future Therapeutic Directions.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 795, doi. 10.1016/j.clml.2022.07.013
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Asparaginase--Understanding and Overcoming Toxicities in Adults with ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 787, doi. 10.1016/j.clml.2022.08.009
- By:
- Publication type:
- Article
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e1009, doi. 10.1016/j.clml.2022.07.015
- By:
- Publication type:
- Article
Treatment Landscape of Relapsed/Refractory Mantle Cell Lymphoma: An Updated Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e1019, doi. 10.1016/j.clml.2022.07.017
- By:
- Publication type:
- Article
Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e1000, doi. 10.1016/j.clml.2022.07.002
- By:
- Publication type:
- Article
Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e992, doi. 10.1016/j.clml.2022.07.005
- By:
- Publication type:
- Article
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e981, doi. 10.1016/j.clml.2022.07.006
- By:
- Publication type:
- Article
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e972, doi. 10.1016/j.clml.2022.07.009
- By:
- Publication type:
- Article
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e959, doi. 10.1016/j.clml.2022.07.004
- By:
- Publication type:
- Article